These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 15661755

  • 21. Long-term proteasome dysfunction in the mouse brain by expression of aberrant ubiquitin.
    Fischer DF, van Dijk R, van Tijn P, Hobo B, Verhage MC, van der Schors RC, Li KW, van Minnen J, Hol EM, van Leeuwen FW.
    Neurobiol Aging; 2009 Jun; 30(6):847-63. PubMed ID: 18760506
    [Abstract] [Full Text] [Related]

  • 22. Defective proteolytic systems in Mybpc3-targeted mice with cardiac hypertrophy.
    Schlossarek S, Englmann DR, Sultan KR, Sauer M, Eschenhagen T, Carrier L.
    Basic Res Cardiol; 2012 Jan; 107(1):235. PubMed ID: 22189562
    [Abstract] [Full Text] [Related]

  • 23. Inhibition of 26S proteasome activity by huntingtin filaments but not inclusion bodies isolated from mouse and human brain.
    Díaz-Hernández M, Valera AG, Morán MA, Gómez-Ramos P, Alvarez-Castelao B, Castaño JG, Hernández F, Lucas JJ.
    J Neurochem; 2006 Sep; 98(5):1585-96. PubMed ID: 16787406
    [Abstract] [Full Text] [Related]

  • 24. Endoplasmic reticulum stress compromises the ubiquitin-proteasome system.
    Menéndez-Benito V, Verhoef LG, Masucci MG, Dantuma NP.
    Hum Mol Genet; 2005 Oct 01; 14(19):2787-99. PubMed ID: 16103128
    [Abstract] [Full Text] [Related]

  • 25. CAG repeat disorder models and human neuropathology: similarities and differences.
    Yamada M, Sato T, Tsuji S, Takahashi H.
    Acta Neuropathol; 2008 Jan 01; 115(1):71-86. PubMed ID: 17786457
    [Abstract] [Full Text] [Related]

  • 26. Application and analysis of the GFPu family of ubiquitin-proteasome system reporters.
    Bence NF, Bennett EJ, Kopito RR.
    Methods Enzymol; 2005 Jan 01; 399():481-90. PubMed ID: 16338377
    [Abstract] [Full Text] [Related]

  • 27. The ubiquitin-proteasome reporter GFPu does not accumulate in neurons of the R6/2 transgenic mouse model of Huntington's disease.
    Bett JS, Cook C, Petrucelli L, Bates GP.
    PLoS One; 2009 Jan 01; 4(4):e5128. PubMed ID: 19352500
    [Abstract] [Full Text] [Related]

  • 28. Protein ubiquitination, degradation and the proteasome in neuro-degenerative disorders: no clear evidence for a significant pathogenetic role of proteasome failure in Alzheimer disease and related disorders.
    Schmitt HP.
    Med Hypotheses; 2006 Jan 01; 67(2):311-7. PubMed ID: 16580788
    [Abstract] [Full Text] [Related]

  • 29. SCA7 mouse models show selective stabilization of mutant ataxin-7 and similar cellular responses in different neuronal cell types.
    Yvert G, Lindenberg KS, Devys D, Helmlinger D, Landwehrmeyer GB, Mandel JL.
    Hum Mol Genet; 2001 Aug 01; 10(16):1679-92. PubMed ID: 11487572
    [Abstract] [Full Text] [Related]

  • 30. 17-DMAG ameliorates polyglutamine-mediated motor neuron degeneration through well-preserved proteasome function in an SBMA model mouse.
    Tokui K, Adachi H, Waza M, Katsuno M, Minamiyama M, Doi H, Tanaka K, Hamazaki J, Murata S, Tanaka F, Sobue G.
    Hum Mol Genet; 2009 Mar 01; 18(5):898-910. PubMed ID: 19066230
    [Abstract] [Full Text] [Related]

  • 31. Acute polyglutamine expression in inducible mouse model unravels ubiquitin/proteasome system impairment and permanent recovery attributable to aggregate formation.
    Ortega Z, Díaz-Hernández M, Maynard CJ, Hernández F, Dantuma NP, Lucas JJ.
    J Neurosci; 2010 Mar 10; 30(10):3675-88. PubMed ID: 20220001
    [Abstract] [Full Text] [Related]

  • 32. Interferon β induces clearance of mutant ataxin 7 and improves locomotion in SCA7 knock-in mice.
    Chort A, Alves S, Marinello M, Dufresnois B, Dornbierer JG, Tesson C, Latouche M, Baker DP, Barkats M, El Hachimi KH, Ruberg M, Janer A, Stevanin G, Brice A, Sittler A.
    Brain; 2013 Jun 10; 136(Pt 6):1732-45. PubMed ID: 23518714
    [Abstract] [Full Text] [Related]

  • 33. Spinocerebellar ataxia type 7 associated with pigmentary retinal dystrophy.
    Michalik A, Martin JJ, Van Broeckhoven C.
    Eur J Hum Genet; 2004 Jan 10; 12(1):2-15. PubMed ID: 14571264
    [Abstract] [Full Text] [Related]

  • 34. Fluorescent reporters for the ubiquitin-proteasome system.
    Salomons FA, Verhoef LG, Dantuma NP.
    Essays Biochem; 2005 Jan 10; 41():113-28. PubMed ID: 16250901
    [Abstract] [Full Text] [Related]

  • 35. Emerging roles for ubiquitin and protein degradation in neuronal function.
    Yi JJ, Ehlers MD.
    Pharmacol Rev; 2007 Mar 10; 59(1):14-39. PubMed ID: 17329546
    [Abstract] [Full Text] [Related]

  • 36. The ins and outs of a polyglutamine neurodegenerative disease: spinocerebellar ataxia type 1 (SCA1).
    Orr HT.
    Neurobiol Dis; 2000 Jun 10; 7(3):129-34. PubMed ID: 10860780
    [Abstract] [Full Text] [Related]

  • 37. Promyelocytic leukemia protein is redistributed during the formation of intranuclear inclusions independent of polyglutamine expansion: an immunohistochemical study on Marinesco bodies.
    Kumada S, Uchihara T, Hayashi M, Nakamura A, Kikuchi E, Mizutani T, Oda M.
    J Neuropathol Exp Neurol; 2002 Nov 10; 61(11):984-91. PubMed ID: 12430715
    [Abstract] [Full Text] [Related]

  • 38. [Neurodegenerative diseases regulated by ubiquitin-proteasome system].
    Hatakeyama S.
    Rinsho Shinkeigaku; 2006 Nov 10; 46(11):890-2. PubMed ID: 17432211
    [Abstract] [Full Text] [Related]

  • 39. Intranuclear immunolocalization of 14-3-3 protein isoforms in brains with spinocerebellar ataxia type 1.
    Umahara T, Uchihara T, Yagishita S, Nakamura A, Tsuchiya K, Iwamoto T.
    Neurosci Lett; 2007 Mar 06; 414(2):130-5. PubMed ID: 17224237
    [Abstract] [Full Text] [Related]

  • 40. Impaired proteasome activity and accumulation of ubiquitinated substrates in a hereditary neuropathy model.
    Fortun J, Li J, Go J, Fenstermaker A, Fletcher BS, Notterpek L.
    J Neurochem; 2005 Mar 06; 92(6):1531-41. PubMed ID: 15748170
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.